Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Taraxacum mongolicum extract exhibits antimicrobial activity against respiratory tract bacterial strains in vitro and in neonatal rats by enhancing systemic Th1 immunity

Chengdong Sun , Yan Wang, Xuemei Zhang

Department of Infectious Diseases, Beijing Jishuitan Hosipital, Beijing, 100009, China;

For correspondence:- Chengdong Sun Email: SybleLath@yahoo.com Tel:+861058516688

Accepted: 20 August 2018 Published: 30 September 2018

Citation: Sun C, Wang Y, Zhang X. Taraxacum mongolicum extract exhibits antimicrobial activity against respiratory tract bacterial strains in vitro and in neonatal rats by enhancing systemic Th1 immunity. Trop J Pharm Res 2018; 17(9):1833-1838 doi: 10.4314/tjpr.v17i9.22

© 2018 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To study the antimicrobial activity of the Taraxacum mongolicum extract against respiratory infection-causing bacterial strains in vitro and in neonatal rats.

Methods: The in vitro antibacterial activity was assessed by micro-dilution method. Antioxidant activity was determined by ferric reducing antioxidant power (FRAP), nitro blue tetrazolium (NBT) and 2, 2-diphenyl-1-picrylhydrazyl (DPPH) assays. In vivo antimicrobial activity was evaluated in neonatal rat model. Interleukin (IL)-2 (IL-2) and gamma interferon (IFN-γ) were estimated using enzyme-linked immunosorbent assay (ELISA).

Results: The hydro-methanol extract of T. mongolicum contained high levels of phenolics and flavonoids, and exhibited strong antimicrobial activity against respiratory infection-causing bacterial species with MICs of 25 - 100 µg/ml, and MBCs of 55 - 215 µg/ml. The highest and lowest antimicrobial activities were observed against Streptococcus pneumonia and Haemophilus influenza, respectively. The extract at doses of 25 and 50 mg/kg exerted protective effects against Streptococcus pneumonia-infected neonatal rats by boosting their Th1 immunity. It enhanced the production of interleukin (IL)-2, concomitant with decreased production of interferon (IFN)-γ in neonatal rats. The extract contained isoetin, hesperidin, naringenin, kaempferol, sinapinic and gallic acid.

Conclusion: These results suggest that the hydro-methanolic extract of Taraxacum mongolicum and its constituents can be potentially developed for use in the management of respiratory bacterial infections.

Keywords: Respiratory tract infection, Interleukin, Taraxacum mongolicum, Immunity, Neonatal rats